{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:50:54Z","timestamp":1788814254744,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s12149-026-02175-3","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T06:32:53Z","timestamp":1772519573000},"page":"723-730","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic value of \u2076\u2078Ga-DOTATATE PET\/CT volumetric parameters in differentiating adrenal lesions"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8270-9480","authenticated-orcid":false,"given":"Dilara","family":"Denizmen Zorba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6945-2003","authenticated-orcid":false,"given":"Duygu","family":"Has Simsek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3133-3134","authenticated-orcid":false,"given":"Dilsat Firat","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3786-8052","authenticated-orcid":false,"given":"Emine Goknur","family":"Isik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0360-358X","authenticated-orcid":false,"given":"Zeynep Gozde","family":"Ozkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1267-2379","authenticated-orcid":false,"given":"Yasemin","family":"Sanli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9989-6473","authenticated-orcid":false,"given":"Hulya","family":"Hacisahinogullari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5576-9496","authenticated-orcid":false,"given":"Yalin","family":"Iscan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1158-5361","authenticated-orcid":false,"given":"Serkan","family":"Kuyumcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"issue":"6","key":"2175_CR1","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1530\/EJE-10-1147","volume":"164","author":"M Terzolo","year":"2011","unstructured":"Terzolo M, Stigliano A, Chiodini I, Loli P, Furlani L, Arnaldi G, et al. AME position statement on adrenal incidentaloma. Eur J Endocrinol. 2011;164(6):851\u201370.","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2175_CR2","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0025-7125(16)30088-8","volume":"79","author":"SS Werbel","year":"1995","unstructured":"Werbel SS, Ober KP. Pheochromocytoma: update on diagnosis, localization, and management. Med Clin North Am. 1995;79(1):131\u201353.","journal-title":"Med Clin North Am"},{"key":"2175_CR3","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvac004","author":"GFC Fagundes","year":"2022","unstructured":"Fagundes GFC, Almeida MQ. Perioperative management of pheochromocytomas and sympathetic paragangliomas. J Endocr Soc. 2022. https:\/\/doi.org\/10.1210\/jendso\/bvac004.","journal-title":"J Endocr Soc"},{"issue":"2","key":"2175_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2019.101346","volume":"34","author":"E Sbardella","year":"2020","unstructured":"Sbardella E, Grossman AB. Pheochromocytoma: an approach to diagnosis. Best Practice & Research Clinical Endocrinology & Metabolism. 2020;34(2):101346.","journal-title":"Best Practice & Research Clinical Endocrinology & Metabolism"},{"issue":"11","key":"2175_CR5","doi-asserted-by":"publisher","first-page":"S251","DOI":"10.1016\/j.jacr.2021.08.010","volume":"18","author":"RN Mody","year":"2021","unstructured":"Mody RN, Remer EM, Nikolaidis P, Khatri G, Dogra VS, Ganeshan D, et al. ACR appropriateness criteria\u00ae adrenal mass evaluation: 2021 update. J Am Coll Radiol. 2021;18(11):S251\u201367.","journal-title":"J Am Coll Radiol"},{"issue":"5","key":"2175_CR6","doi-asserted-by":"publisher","first-page":"450","DOI":"10.4158\/EP.15.5.450","volume":"15","author":"MA Zeiger","year":"2009","unstructured":"Zeiger MA, Thompson GB, Duh QY, Hamrahian AH, Angelos P, Elaraj D, et al. American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons Medical Guidelines for the Management of Adrenal Incidentalomas: executive summary of recommendations. Endocr Pract. 2009;15(5):450\u20133.","journal-title":"Endocr Pract"},{"issue":"8","key":"2175_CR7","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.jacr.2017.05.001","volume":"14","author":"WW Mayo-Smith","year":"2017","unstructured":"Mayo-Smith WW, Song JH, Boland GL, Francis IR, Israel GM, Mazzaglia PJ, et al. Management of Incidental Adrenal Masses: A White Paper of the ACR Incidental Findings Committee. J Am Coll Radiol. 2017;14(8):1038\u201344.","journal-title":"J Am Coll Radiol"},{"issue":"11","key":"2175_CR8","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1001\/jama.287.11.1427","volume":"287","author":"JW Lenders","year":"2002","unstructured":"Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P, et al. Biochemical diagnosis of pheochromocytoma: which test is best? JAMA. 2002;287(11):1427\u201334.","journal-title":"JAMA"},{"issue":"1","key":"2175_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.currproblcancer.2014.01.001","volume":"38","author":"VL Martucci","year":"2014","unstructured":"Martucci VL, Pacak K. Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment. Curr Probl Cancer. 2014;38(1):7\u201341.","journal-title":"Curr Probl Cancer"},{"issue":"6","key":"2175_CR10","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.2214\/AJR.15.15318","volume":"206","author":"N Schieda","year":"2016","unstructured":"Schieda N, Alrashed A, Flood TA, Samji K, Shabana W, McInnes MD. Comparison of quantitative MRI and CT washout analysis for differentiation of adrenal pheochromocytoma from adrenal adenoma. AJR Am J Roentgenol. 2016;206(6):1141\u20138.","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"2175_CR11","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.2214\/AJR.16.17758","volume":"208","author":"N Schieda","year":"2017","unstructured":"Schieda N, Siegelman ES. Update on CT and MRI of adrenal nodules. AJR Am J Roentgenol. 2017;208(6):1206\u201317.","journal-title":"AJR Am J Roentgenol"},{"issue":"12","key":"2175_CR12","doi-asserted-by":"publisher","first-page":"8247","DOI":"10.1007\/s00330-022-08867-4","volume":"32","author":"R Gerson","year":"2022","unstructured":"Gerson R, Tu W, Abreu-Gomez J, Udare A, McPhedran R, Ramsay T, et al. Evaluation of the T2-weighted (T2W) adrenal MRI calculator to differentiate adrenal pheochromocytoma from lipid-poor adrenal adenoma. Eur Radiol. 2022;32(12):8247\u201355.","journal-title":"Eur Radiol"},{"issue":"9","key":"2175_CR13","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.2967\/jnumed.108.058701","volume":"50","author":"GA Wiseman","year":"2009","unstructured":"Wiseman GA, Pacak K, O\u2019Dorisio MS, Neumann DR, Waxman AD, Mankoff DA, et al. Usefulness of 123I-MIBG scintigraphy in the evaluation of patients with known or suspected primary or metastatic pheochromocytoma or paraganglioma: results from a prospective multicenter trial. J Nucl Med. 2009;50(9):1448\u201354.","journal-title":"J Nucl Med"},{"issue":"11","key":"2175_CR14","doi-asserted-by":"publisher","first-page":"5150","DOI":"10.1210\/jc.2003-030262","volume":"88","author":"J Mundschenk","year":"2003","unstructured":"Mundschenk J, Unger N, Schulz S, Hollt V, Schulz S, Steinke R, et al. Somatostatin receptor subtypes in human pheochromocytoma: subcellular expression pattern and functional relevance for octreotide scintigraphy. J Clin Endocrinol Metab. 2003;88(11):5150\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2175_CR15","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2967\/jnumed.118.211706","volume":"60","author":"S Han","year":"2019","unstructured":"Han S, Suh CH, Woo S, Kim YJ, Lee JJ. Performance of 68Ga-DOTA\u2013conjugated somatostatin receptor\u2013targeting peptide PET in detection of pheochromocytoma and paraganglioma: a systematic review and metaanalysis. J Nucl Med. 2019;60(3):369\u201376.","journal-title":"J Nucl Med"},{"key":"2175_CR16","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1007\/s00259-019-04398-1","volume":"46","author":"D Ta\u00efeb","year":"2019","unstructured":"Ta\u00efeb D, Hicks RJ, Hindi\u00e9 E, Guillet BA, Avram A, Ghedini P, et al. European association of nuclear medicine practice guideline\/society of nuclear medicine and molecular imaging procedure standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging. 2019;46:2112\u201337.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"2175_CR17","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1097\/MNM.0000000000000522","volume":"37","author":"U Abdulrezzak","year":"2016","unstructured":"Abdulrezzak U, Kurt YK, Kula M, Tutus A. Combined imaging with 68Ga-DOTA-TATE and 18F-FDG PET\/CT on the basis of volumetric parameters in neuroendocrine tumors. Nucl Med Commun. 2016;37(8):874\u201381.","journal-title":"Nucl Med Commun"},{"issue":"10","key":"2175_CR18","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.2967\/jnumed.121.262928","volume":"63","author":"R Fonti","year":"2022","unstructured":"Fonti R, Panico M, Pellegrino S, Pulcrano A, Vastarella LA, Torbati AHM, et al. Heterogeneity of SSTR2 Expression Assessed by <\u2009sup>68\u2009Ga-DOTATOC PET\/CT Using Coefficient of Variation in Patients with Neuroendocrine Tumors. J Nucl Med. 2022;63(10):1509\u201314.","journal-title":"J Nucl Med"},{"issue":"6","key":"2175_CR19","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1007\/s12149-013-0718-4","volume":"27","author":"S Kuyumcu","year":"2013","unstructured":"Kuyumcu S, Ozkan ZG, Sanli Y, Yilmaz E, Mudun A, Adalet I, et al. Physiological and tumoral uptake of (68)Ga-DOTATATE: standardized uptake values and challenges in interpretation. Ann Nucl Med. 2013;27(6):538\u201345.","journal-title":"Ann Nucl Med"},{"issue":"7","key":"2175_CR20","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1007\/s00259-015-3268-2","volume":"43","author":"A Archier","year":"2016","unstructured":"Archier A, Varoquaux A, Garrigue P, Montava M, Guerin C, Gabriel S, et al. Prospective comparison of 68Ga-DOTATATE and 18F-FDOPA PET\/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases. Eur J Nucl Med Mol Imaging. 2016;43(7):1248\u201357.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"2175_CR21","doi-asserted-by":"publisher","first-page":"342","DOI":"10.2214\/AJR.21.26071","volume":"218","author":"A Jha","year":"2022","unstructured":"Jha A, Patel M, Carrasquillo JA, Ling A, Millo C, Saboury B, et al. Sporadic primary pheochromocytoma: a prospective intraindividual comparison of six imaging tests (CT, MRI, and PET\/CT using (68)Ga-DOTATATE, FDG, (18)F-FDOPA, and (18)F-FDA). AJR Am J Roentgenol. 2022;218(2):342\u201350.","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"2175_CR22","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/cen.13737","volume":"89","author":"ML Gild","year":"2018","unstructured":"Gild ML, Naik N, Hoang J, Hsiao E, McGrath RT, Sywak M, et al. Role of DOTATATE-PET\/CT in preoperative assessment of phaeochromocytoma and paragangliomas. Clin Endocrinol (Oxf). 2018;89(2):139\u201347.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11S","key":"2175_CR23","first-page":"S251","volume":"18","author":"I Urological","year":"2021","unstructured":"Expert Panel on, Urological I, Mody RN, Remer EM, Nikolaidis P, Khatri G, Dogra VS, et al. ACR Appropriateness Criteria(R) Adrenal Mass Evaluation: 2021 Update. J Am Coll Radiol. 2021;18(11S):S251\u201367.","journal-title":"J Am Coll Radiol"},{"issue":"3","key":"2175_CR24","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/cen.12482","volume":"81","author":"A van Berkel","year":"2014","unstructured":"van Berkel A, Pacak K, Lenders JW. Should every patient diagnosed with a phaeochromocytoma have a \u00b9\u00b2\u00b3 I-MIBG scintigraphy? Clin Endocrinol (Oxf). 2014;81(3):329\u201333.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2175_CR25","doi-asserted-by":"publisher","first-page":"869","DOI":"10.2967\/jnumed.121.262797","volume":"63","author":"M Weber","year":"2022","unstructured":"Weber M, Schmitz J, Maric I, Pabst K, Umutlu L, Walz M, et al. Diagnostic performance of (124)I-metaiodobenzylguanidine PET\/CT in patients with pheochromocytoma. J Nucl Med. 2022;63(6):869\u201374.","journal-title":"J Nucl Med"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-026-02175-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-026-02175-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-026-02175-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T08:19:38Z","timestamp":1779956378000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-026-02175-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["2175"],"URL":"https:\/\/doi.org\/10.1007\/s12149-026-02175-3","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"assertion":[{"value":"22 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}